Dose Finding Versus Speed in Seamless Immuno-Oncology Drug Development

J Clin Pharmacol. 2017 Oct:57 Suppl 10:S143-S145. doi: 10.1002/jcph.1001.
No abstract available

Keywords: PK-PD; immuno-oncology; optimal dose.

MeSH terms

  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Agents / therapeutic use*
  • Dose-Response Relationship, Drug
  • Drug Development / methods*
  • Humans
  • Immunologic Factors / administration & dosage*
  • Immunologic Factors / therapeutic use*
  • Neoplasms / drug therapy*
  • Time Factors

Substances

  • Antineoplastic Agents
  • Immunologic Factors